ATA582780A - Verfahren zur herstellung von 1-(8-chinolyl)2-pyrrolidinon und dessen saeureadditionssalzen - Google Patents

Verfahren zur herstellung von 1-(8-chinolyl)2-pyrrolidinon und dessen saeureadditionssalzen

Info

Publication number
ATA582780A
ATA582780A AT0582780A AT582780A ATA582780A AT A582780 A ATA582780 A AT A582780A AT 0582780 A AT0582780 A AT 0582780A AT 582780 A AT582780 A AT 582780A AT A582780 A ATA582780 A AT A582780A
Authority
AT
Austria
Prior art keywords
chinolyl
pyrrolidinone
producing
acid addition
addition salts
Prior art date
Application number
AT0582780A
Other languages
English (en)
Other versions
AT375363B (de
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ATA582780A publication Critical patent/ATA582780A/de
Application granted granted Critical
Publication of AT375363B publication Critical patent/AT375363B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/40Nitrogen atoms attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT0582780A 1979-11-30 1980-11-28 Verfahren zur herstellung von 1-(8-chinolyl)2-pyrrolidinon und dessen saeureadditionssalzen AT375363B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7941409 1979-11-30

Publications (2)

Publication Number Publication Date
ATA582780A true ATA582780A (de) 1983-12-15
AT375363B AT375363B (de) 1984-07-25

Family

ID=10509524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0582780A AT375363B (de) 1979-11-30 1980-11-28 Verfahren zur herstellung von 1-(8-chinolyl)2-pyrrolidinon und dessen saeureadditionssalzen

Country Status (18)

Country Link
US (1) US4366158A (de)
EP (1) EP0030023A3 (de)
JP (1) JPS5699475A (de)
KR (1) KR830004293A (de)
AR (1) AR228442A1 (de)
AT (1) AT375363B (de)
AU (1) AU6495080A (de)
CA (1) CA1156235A (de)
DK (1) DK506480A (de)
ES (1) ES497242A0 (de)
FI (1) FI803704L (de)
GB (1) GB2063868B (de)
GR (1) GR71918B (de)
HU (1) HU185224B (de)
IL (1) IL61580A (de)
IT (1) IT1221040B (de)
NZ (1) NZ195688A (de)
ZA (1) ZA807467B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004000260T2 (de) 2003-07-22 2006-08-24 Arena Pharmaceuticals, Inc., San Diego Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
GB0507198D0 (en) * 2005-04-08 2005-05-18 Sb Pharmco Inc Process for preparing bicyclic compounds
GB0519758D0 (en) * 2005-09-28 2005-11-09 Glaxo Group Ltd Novel process
US9084742B2 (en) 2007-12-12 2015-07-21 Axovant Sciences Ltd. Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
MX2017016413A (es) 2015-06-12 2018-08-01 Axovant Sciences Gmbh Derivados de diaril y arilheteroaril urea como moduladores del receptor 5ht2a de serotonina útiles para la profilaxis y el tratamineto de un trastorno conductual del sueño rem.
JP2018520187A (ja) 2015-07-15 2018-07-26 アクソヴァント サイエンシーズ ゲゼルシャフト ミット ベシュレンクテル ハフツングAxovant Sciences GmbH 神経変性疾患と関連する幻覚の予防および処置のために有用な5−ht2aセロトニン受容体のモジュレーターとしてのジアリールおよびアリールヘテロアリール尿素誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4143151A (en) * 1978-07-03 1979-03-06 The Dow Chemical Company Method for treating hyperglycemia in mammals using arylamino benzoic acids

Also Published As

Publication number Publication date
AU6495080A (en) 1981-06-04
IT1221040B (it) 1990-06-21
HU185224B (en) 1984-12-28
IT8050277A0 (it) 1980-11-28
US4366158A (en) 1982-12-28
ZA807467B (en) 1982-07-28
EP0030023A2 (de) 1981-06-10
JPS5699475A (en) 1981-08-10
ES8203882A1 (es) 1982-04-01
CA1156235A (en) 1983-11-01
GB2063868A (en) 1981-06-10
IL61580A (en) 1984-06-29
GR71918B (de) 1983-08-17
ES497242A0 (es) 1982-04-01
EP0030023A3 (de) 1981-09-02
IL61580A0 (en) 1980-12-31
KR830004293A (ko) 1983-07-09
AT375363B (de) 1984-07-25
AR228442A1 (es) 1983-03-15
NZ195688A (en) 1984-09-28
DK506480A (da) 1981-05-31
FI803704L (fi) 1981-05-31
GB2063868B (en) 1984-02-29

Similar Documents

Publication Publication Date Title
AT363457B (de) Verfahren zur herstellung von neuen substituierten 1-(3-aminosulfonylphenyl)-2-alkylaminoaethanolen und deren saeureadditionssalzen
AT363195B (de) Verfahren zur herstellung von n-substituierten 9,10-dihydrolysergsaeureestern
AT361937B (de) Verfahren zur herstellung von neuen 4-acyl- aminophenyl-aethanolaminen und deren saeure- additionssalzen
AT354436B (de) Verfahren zur herstellung von neuem 2-brom-6- fluor-n-2-imidazolidinyliden-benzamin und dessen saeureadditionssalzen
AT376983B (de) Verfahren zur herstellung von neuen 7-acylaminocephalosporansaeurederivaten und deren salzen
AT375363B (de) Verfahren zur herstellung von 1-(8-chinolyl)2-pyrrolidinon und dessen saeureadditionssalzen
AT369744B (de) Verfahren zur herstellung von 6-beta-jod -penicillansaeure-derivaten
AT379382B (de) Verfahren zur herstellung von neuen n-substituierten aziridin-2-carbonsaeurederivaten
AT372677B (de) Verfahren zur herstellung von neuen basischen oximaethern und von deren saeureadditionssalzen und quaternaeren ammoniumsalzen
AT359056B (de) Verfahren zur herstellung von teilweise neuen n-substituierten alpha-ketocarbonsaeureamiden
AT363923B (de) Verfahren zur herstellung von neuen 8-amino-alkyltetracyclononanen und von deren saeureadditionssalzen
AT382151B (de) Verfahren zur herstellung von apovincaminsaeureester-derivaten
AT370106B (de) Verfahren zur herstellung von neuen penicillansaeurederivaten
AT374180B (de) Verfahren zur herstellung von 6-chlor-alpha-methyl-carbazol-2-essigsaeure
AT360033B (de) Verfahren zur herstellung von neuen tetrahydro- -s-triazinthionen und deren saeure- additionssalzen
AT364822B (de) Verfahren zur herstellung von neuen 4acetamidophenyl-alpha-(2-methyl-ind(en/ol)-3-yl)-acetaten und deren saeureadditionssalzen
AT357692B (de) Verfahren zur herstellung von 4-desacetoxy- -vinblastin und dessen saeureadditionssalzen
AT374804B (de) Verfahren zur herstellung von 14-oxo-15-hydroxy- imino-e-homoeburnan und den saeureadditionssalzen davon
AT376198B (de) Verfahren zur herstellung von 1-(2allyloxyphenoxy)-3-isopropylamino-2-propanol und dessen salzen
AT365559B (de) Verfahren zur herstellung von aminopropandiolmono-aethern und deren saeureadditionssalzen
AT369740B (de) Verfahren zur herstellung von neuen thiodibenzthiepinen und deren saeureadditionssalzen
ATA278581A (de) Verfahren zur herstellung von neuen n-substituierten moranolinderivaten und ihrer saeureadditionssalze
AT373888B (de) Verfahren zur herstellung von neuen 4-piperidinaminen und deren saeureadditionssalzen
AT364365B (de) Verfahren zur herstellung von neuen substituierten octahydropyrazinopyrimidinonen und deren saeureadditionssalzen
ATA148580A (de) Verfahren zur herstellung von neuen 4-acyl- aminophenyl-aethanolaminen und deren saeure- additionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee